ALNY ALNYLAM PHARMACEUTICALS, INC.
Nasdaq · SEC CIK 1178670 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $53.75M 30 sales by 7 insiders
- Filings on record
- 236 since 2021-07-14, latest 2026-09-22 16:07
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Greenstreet Yvonne | CEO, Dir | — | $24.46M |
| Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | — | $10.74M |
| Garg Pushkal | EVP Chief R, D | — | $8.12M |
| Poulton Jeffrey V. | EVP, CFO | — | $4.95M |
| Tanguler Tolga | EVP, Chief Commercial Off | — | $3.06M |
| McLaughlin Melissa | CHRO | — | $1.27M |
| PYOTT DAVID E I | Dir | — | $1.15M |
| Reitan Colleen F | Dir | — | — |
| Sigal Charles Elliott | Dir | — | — |
| Arbuckle Stuart A | Dir | — | — |
Transactions 290
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-12 | 2025-04-16 | ALNY | Reitan Colleen F | Dir | S - Sale | $232.86 | -36 | 0 | -100% | -$8,383 |
| D | 2025-05-12 | 2025-05-08 | ALNY | Reitan Colleen F | Dir | A - Grant | $0.00 | +775 | 775 | New | $0 |
| D | 2025-05-12 | 2025-05-08 | ALNY | SCHULMAN AMY W | Dir | A - Grant | $0.00 | +775 | 12.0K | +7% | $0 |
| D | 2025-05-12 | 2025-05-08 | ALNY | BONNEY MICHAEL W | Dir | A - Grant | $0.00 | +775 | 16.8K | +5% | $0 |
| D | 2025-05-12 | 2025-05-08 | ALNY | PYOTT DAVID E I | Dir | A - Grant | $0.00 | +775 | 911 | +570% | $0 |
| D | 2025-05-12 | 2025-05-08 | ALNY | KELLOGG PETER N | Dir | A - Grant | $0.00 | +775 | 775 | New | $0 |
| D | 2025-05-12 | 2025-05-08 | ALNY | HAMBURG MARGARET A | Dir | A - Grant | $0.00 | +775 | 911 | +570% | $0 |
| D | 2025-05-12 | 2025-05-08 | ALNY | Bertozzi Carolyn R | Dir | A - Grant | $0.00 | +775 | 775 | New | $0 |
| 2025-05-06 | 2025-05-02 | ALNY | Greenstreet Yvonne | CEO, Dir | G - Gift | $0.00 | -41.3K | 57.3K | -42% | $0 | |
| D | 2025-03-25 | 2025-03-24 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | M - OptEx | $42.22 | +5,445 | 25.7K | +27% | +$229.9K |
| DM | 2025-03-25 | 2025-03-21+ | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale+OE | $293.36 | -9,766 | 20.2K | -33% | -$2.86M |
| D | 2025-03-25 | 2025-03-24 | ALNY | PYOTT DAVID E I | Dir | M - OptEx | $88.95 | +7,440 | 7,576 | +5,471% | +$661.8K |
| D | 2025-03-25 | 2025-03-24 | ALNY | PYOTT DAVID E I | Dir | S - Sale+OE | $299.00 | -7,440 | 136 | -98% | -$2.22M |
| D | 2025-03-14 | 2025-03-13 | ALNY | SCHULMAN AMY W | Dir | M - OptEx | $131.21 | +2,750 | 11.2K | +33% | +$360.8K |
| DM | 2025-03-05 | 2025-03-03 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $243.78 | -471 | 28.4K | -2% | -$114.8K |
| D | 2025-03-05 | 2025-03-03 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +14.1K | 28.5K | +99% | $0 |
| DM | 2025-03-05 | 2025-03-03 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale | $243.79 | -3,877 | 99.5K | -4% | -$945.2K |
| D | 2025-03-05 | 2025-03-03 | ALNY | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +18.0K | 102.5K | +21% | $0 |
| D | 2025-03-05 | 2025-03-03 | ALNY | Hesslein Robert W. | EVP, CLO, Sec | A - Grant | $0.00 | +757 | 8,002 | +10% | $0 |
| DM | 2025-03-05 | 2025-03-03+ | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $242.92 | -2,557 | 26.4K | -9% | -$621.2K |
| D | 2025-03-05 | 2025-03-03 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +14.1K | 27.1K | +109% | $0 |
| DM | 2025-03-05 | 2025-03-03 | ALNY | Poulton Jeffrey V. | EVP, CFO | S - Sale | $243.78 | -1,264 | 48.7K | -3% | -$308.1K |
| D | 2025-03-05 | 2025-03-03 | ALNY | Poulton Jeffrey V. | EVP, CFO | A - Grant | $0.00 | +15.1K | 49.0K | +45% | $0 |
| DM | 2025-03-05 | 2025-03-03+ | ALNY | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | S - Sale | $242.94 | -2,755 | 13.9K | -17% | -$669.3K |
| D | 2025-03-05 | 2025-03-03 | ALNY | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | A - Grant | $0.00 | +3,871 | 16.3K | +31% | $0 |
| DM | 2025-03-03 | 2025-02-28 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale+OE | $241.68 | -513 | 14.8K | -3% | -$124.0K |
| D | 2025-03-03 | 2025-02-27 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | M - OptEx | $0.00 | +1,667 | 14.9K | +13% | $0 |
| M | 2025-03-03 | 2025-02-28 | ALNY | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | S - Sale | $241.69 | -496 | 12.8K | -4% | -$119.9K |
| DM | 2025-03-03 | 2025-02-28 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale+OE | $241.69 | -935 | 13.7K | -6% | -$226.0K |
| D | 2025-03-03 | 2025-02-27 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | M - OptEx | $0.00 | +1,908 | 13.9K | +16% | $0 |
| D | 2025-03-03 | 2025-02-27 | ALNY | Greenstreet Yvonne | CEO, Dir | M - OptEx | $0.00 | +5,921 | 87.4K | +7% | $0 |
| DM | 2025-03-03 | 2025-02-28 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $241.69 | -2,900 | 87.0K | -3% | -$700.9K |
| D | 2025-03-03 | 2025-02-27 | ALNY | Poulton Jeffrey V. | EVP, CFO | M - OptEx | $0.00 | +1,908 | 34.7K | +6% | $0 |
| DM | 2025-03-03 | 2025-02-28 | ALNY | Poulton Jeffrey V. | EVP, CFO | S - Sale+OE | $241.70 | -796 | 33.9K | -2% | -$192.4K |
| 2025-02-18 | 2025-02-13 | ALNY | Poulton Jeffrey V. | EVP, CFO | A - Grant | $0.00 | +3,109 | 33.8K | +10% | $0 | |
| M | 2025-02-18 | 2025-02-14 | ALNY | Poulton Jeffrey V. | EVP, CFO | S - Sale | $255.17 | -967 | 32.8K | -3% | -$246.7K |
| M | 2025-02-18 | 2025-02-14 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale | $255.17 | -1,213 | 81.6K | -1% | -$309.5K |
| 2025-02-18 | 2025-02-13 | ALNY | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +3,859 | 82.7K | +5% | $0 | |
| M | 2025-02-18 | 2025-02-14+ | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $253.43 | -3,109 | 12.4K | -20% | -$787.9K |
| 2025-02-18 | 2025-02-13 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +3,109 | 15.1K | +26% | $0 | |
| M | 2025-02-18 | 2025-02-14+ | ALNY | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | S - Sale | $252.71 | -2,103 | 13.0K | -14% | -$531.4K |
| 2025-02-18 | 2025-02-13 | ALNY | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | A - Grant | $0.00 | +2,103 | 15.0K | +16% | $0 | |
| DM | 2025-01-29 | 2025-01-27 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | M - OptEx | $88.95 | +48.9K | 39.6K | New | +$4.35M |
| D | 2025-01-29 | 2025-01-27 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale+OE | $285.00 | -52.6K | 12.0K | -81% | -$14.99M |
| D | 2025-01-24 | 2025-01-23 | ALNY | SHARP PHILLIP A | Dir | S - Sale+OE | $275.00 | -11.2K | 0 | -100% | -$3.09M |
| D | 2025-01-24 | 2025-01-23 | ALNY | SHARP PHILLIP A | Dir | M - OptEx | $131.21 | +11.2K | 11.2K | New | +$1.48M |
| M | 2024-12-13 | 2024-12-12 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $251.00 | -1,752 | 15.8K | -10% | -$439.8K |
| 2024-11-27 | 2024-11-25 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +3,434 | 19.1K | +22% | $0 | |
| M | 2024-11-27 | 2024-11-26 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $250.98 | -1,682 | 17.5K | -9% | -$422.1K |
| 2024-11-27 | 2024-11-25 | ALNY | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +10.7K | 84.1K | +15% | $0 | |
| M | 2024-11-27 | 2024-11-26 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale | $250.98 | -5,219 | 78.9K | -6% | -$1.31M |
| M | 2024-11-27 | 2024-11-26 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $250.98 | -1,469 | 13.2K | -10% | -$368.7K |
| 2024-11-27 | 2024-11-25 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +3,000 | 14.7K | +26% | $0 | |
| M | 2024-11-27 | 2024-11-26 | ALNY | Poulton Jeffrey V. | EVP, CFO | S - Sale | $250.98 | -1,682 | 30.7K | -5% | -$422.1K |
| 2024-11-27 | 2024-11-25 | ALNY | Poulton Jeffrey V. | EVP, CFO | A - Grant | $0.00 | +3,434 | 32.3K | +12% | $0 | |
| M | 2024-11-27 | 2024-11-26+ | ALNY | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | S - Sale | $251.65 | -3,000 | 15.9K | -16% | -$754.9K |
| 2024-11-27 | 2024-11-25 | ALNY | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | A - Grant | $0.00 | +3,000 | 15.9K | +23% | $0 | |
| 2024-10-10 | 2024-10-08 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +96 | 15.7K | +0.6% | $0 | |
| 2024-10-03 | 2024-10-01 | ALNY | Hesslein Robert W. | EVP, CLO, Sec | A - Grant | $0.00 | +7,245 | 7,245 | New | $0 | |
| D | 2024-08-22 | 2024-08-20 | ALNY | Greenstreet Yvonne | CEO, Dir | M - OptEx | $85.00 | +15.0K | 88.4K | +20% | +$1.27M |
| D | 2024-08-22 | 2024-08-20 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $280.00 | -15.0K | 73.4K | -17% | -$4.20M |
| DM | 2024-08-14 | 2024-08-12 | ALNY | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | S - Sale+OE | $270.99 | -22.0K | 13.0K | -63% | -$5.97M |
| DM | 2024-08-14 | 2024-08-12 | ALNY | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | M - OptEx | $89.09 | +20.7K | 34.9K | +146% | +$1.85M |
| DM | 2024-08-08 | 2024-08-06 | ALNY | Ausiello Dennis A | Dir | S - Sale+OE | $262.00 | -20.2K | 136 | -99% | -$5.31M |
| DM | 2024-08-08 | 2024-08-06 | ALNY | Ausiello Dennis A | Dir | M - OptEx | $119.68 | +20.2K | 20.4K | +14,890% | +$2.42M |
| D | 2024-08-02 | 2024-08-01 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $270.00 | -15.1K | 73.4K | -17% | -$4.09M |
| D | 2024-08-02 | 2024-08-01 | ALNY | Greenstreet Yvonne | CEO, Dir | M - OptEx | $85.00 | +15.1K | 88.6K | +21% | +$1.29M |
| 2024-07-12 | 2024-07-11 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale | $261.00 | -7,093 | 73.4K | -9% | -$1.85M | |
| D | 2024-06-27 | 2024-06-25 | ALNY | SCHULMAN AMY W | Dir | S - Sale+OE | $240.00 | -8,500 | 8,436 | -50% | -$2.04M |
| D | 2024-06-27 | 2024-06-25 | ALNY | SCHULMAN AMY W | Dir | M - OptEx | $131.21 | +8,500 | 16.9K | +101% | +$1.12M |
| M | 2024-06-26 | 2024-06-25 | ALNY | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | S - Sale | $230.99 | -1,198 | 15.3K | -7% | -$276.7K |
| 2024-06-26 | 2024-06-24 | ALNY | Fitzgerald Kevin Joseph | CSO, EVP, Head of Research | A - Grant | $0.00 | +2,498 | 15.4K | +19% | $0 | |
| DM | 2024-06-26 | 2024-06-24 | ALNY | PYOTT DAVID E I | Dir | M - OptEx | $80.76 | +32.5K | 32.6K | +23,860% | +$2.62M |
| DM | 2024-06-26 | 2024-06-24 | ALNY | PYOTT DAVID E I | Dir | S - Sale+OE | $220.69 | -32.5K | 7,606 | -81% | -$7.16M |
| M | 2024-06-26 | 2024-06-25 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale | $231.00 | -1,605 | 13.2K | -11% | -$370.7K |
| 2024-06-26 | 2024-06-24 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +3,278 | 13.3K | +33% | $0 | |
| M | 2024-06-26 | 2024-06-25 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale | $230.99 | -2,103 | 17.5K | -11% | -$485.8K |
| 2024-06-26 | 2024-06-24 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +4,295 | 17.7K | +32% | $0 | |
| M | 2024-06-26 | 2024-06-25 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale | $230.99 | -8,301 | 88.5K | -9% | -$1.92M |
| 2024-06-26 | 2024-06-24 | ALNY | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +17.0K | 88.8K | +24% | $0 | |
| 2024-06-26 | 2024-06-24 | ALNY | Poulton Jeffrey V. | EVP, CFO | A - Grant | $0.00 | +3,278 | 30.5K | +12% | $0 | |
| M | 2024-06-26 | 2024-06-25 | ALNY | Poulton Jeffrey V. | EVP, CFO | S - Sale | $231.00 | -1,605 | 30.0K | -5% | -$370.7K |
| D | 2024-05-31 | 2024-05-29 | ALNY | SCHULMAN AMY W | Dir | M - OptEx | $66.83 | +30.0K | 30.1K | +22,059% | +$2.00M |
| DM | 2024-05-31 | 2024-05-29 | ALNY | SCHULMAN AMY W | Dir | S - Sale+OE | $148.60 | -21.7K | 20.0K | -52% | -$3.22M |
| D | 2024-03-05 | 2024-03-01 | ALNY | Greenstreet Yvonne | CEO, Dir | A - Grant | $0.00 | +23.8K | 71.9K | +49% | $0 |
| D | 2024-03-05 | 2024-03-01 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | A - Grant | $0.00 | +4,751 | 9,987 | +91% | $0 |
| D | 2024-03-05 | 2024-03-01 | ALNY | Poulton Jeffrey V. | EVP, CFO | A - Grant | $0.00 | +7,741 | 27.2K | +40% | $0 |
| D | 2024-03-05 | 2024-03-01 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +4,751 | 13.4K | +55% | $0 |
| DM | 2024-03-01 | 2024-02-29 | ALNY | SHARP PHILLIP A | Dir | S - Sale+OE | $151.34 | -30.0K | 516 | -98% | -$4.54M |
| D | 2024-03-01 | 2024-02-29 | ALNY | SHARP PHILLIP A | Dir | M - OptEx | $59.25 | +30.0K | 30.0K | New | +$1.78M |
| DM | 2024-02-29 | 2024-02-28 | ALNY | Franchini Indrani Lall | EVP, CLO, Sec | S - Sale+OE | $155.30 | -329 | 4,143 | -7% | -$51.1K |
| D | 2024-02-29 | 2024-02-27 | ALNY | Franchini Indrani Lall | EVP, CLO, Sec | M - OptEx | $0.00 | +878 | 4,462 | +24% | $0 |
| DM | 2024-02-29 | 2024-02-28 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | S - Sale+OE | $155.30 | -501 | 5,237 | -9% | -$77.8K |
| D | 2024-02-29 | 2024-02-27 | ALNY | Tanguler Tolga | EVP, Chief Commercial Off | M - OptEx | $0.00 | +1,667 | 5,737 | +41% | $0 |
| DM | 2024-02-29 | 2024-02-28 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | S - Sale+OE | $155.30 | -574 | 8,666 | -6% | -$89.1K |
| D | 2024-02-29 | 2024-02-27 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | M - OptEx | $0.00 | +1,908 | 9,240 | +26% | $0 |
| DM | 2024-02-29 | 2024-02-28 | ALNY | Poulton Jeffrey V. | EVP, CFO | S - Sale+OE | $155.30 | -574 | 19.8K | -3% | -$89.1K |
| D | 2024-02-29 | 2024-02-27 | ALNY | Poulton Jeffrey V. | EVP, CFO | M - OptEx | $0.00 | +1,908 | 20.1K | +11% | $0 |
| DM | 2024-02-29 | 2024-02-28 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $155.31 | -2,932 | 48.1K | -6% | -$455.4K |
| D | 2024-02-29 | 2024-02-27 | ALNY | Greenstreet Yvonne | CEO, Dir | M - OptEx | $0.00 | +5,921 | 51.1K | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations